Translating prescriptions across regulatory bodies
A prescription accepted in the US is not automatically accepted in UAE, KSA, India or the EU; translation, attestation, and re-issue by a locally licensed physician are usually required.
Why this matters to patients
A prescription accepted in the US is not automatically accepted in UAE, KSA, India or the EU; translation, attestation, and re-issue by a locally licensed physician are usually required. This guide is written for patients, caregivers and home-country physicians who are weighing an international procurement against the local standard of care, against a clinical trial, or against waiting for a future local launch.
What the decision actually looks like
The patient-facing question is rarely "which pathway"; it is "which combination of drug, treating physician, country and timeline minimises my clinical and financial risk?" That decision sits at the intersection of clinical urgency, drug availability, family logistics, and out-of-pocket capacity. The pathway is downstream of that decision, not upstream of it.
Where home-country physicians fit
Home-country physicians carry three roles: they confirm the indication, they administer the drug if it is locally administrable, and they own the follow-on monitoring for adverse events and outcomes. A cross-border procurement without a confirmed home-country administering physician is exposed to the single most common failure mode in this work: a drug arrives, and there is no one to give it.
Documents the patient needs
A minimum documentation set: a recent prescription from a physician licensed in the destination country, a treating-physician declaration that the drug is necessary, the patient's passport or national-ID, a current diagnosis letter with ICD-10 code, and a relevant pathology or imaging report. For controlled or REMS-bound drugs, add the REMS enrollment and the prescriber's certification.
Timeline and realistic expectations
Most patient procurements in this category complete in 14-45 days from intake to hand-off. The variance is driven mainly by destination-regulator processing, not by US-source pharmacy speed. Patients should plan around the regulator timeline, not around the pharmacy timeline, and should not rely on expedited processing being granted on first ask.
How to read a quote
A quote should itemise drug cost, cold-chain handling, customs duty, broker fee, and any local hospital receipt fee. A quote that shows a single line item is not a quote; it is a marketing number. A quote that does not include a refund clause is incomplete. A quote that ties refund only to gross negligence and excludes procurement failure is unbalanced toward the operator.
Red flags and scams
The dominant red flags in this space are: prices materially below international list with no explanation, requests for crypto or escrow without a licensed pharmacy of record, refusal to publish a DEA and state-board licence number, and shipment directly to a home address for a drug class that requires hospital-pharmacy receipt. Any one of these is a hard stop.
What "success" looks like
Success in this work is unromantic: the drug arrives on schedule, in spec, at the treating physician, with full documentation and an itemised invoice, and the patient is administered the drug per protocol. The patient is not asked to chase paperwork after the fact, and the operator can produce the temperature-logger report and the chain-of-custody PDF on request.
How Reserve Meds frames this for patients
Reserve Meds is a US-sourced cross-border pharmacy concierge, operating prepay-direct-procurement against published pathway maps, with a US-licensed pharmacist signing off on every prescription, and a treating-physician receipt at the destination. We are not a generics shop, not a clinical-trial recruiter, and not a financing partner. We focus on the operational layer, and we expect the patient to retain their clinical decision-making with their treating physicians.
Frequently asked questions
Should I travel or have the drug shipped?
Cell therapies and complex infusions usually require travel; small molecules and many biologics can be safely shipped to the treating physician.
What if my home physician will not administer the drug?
Identify a treating physician before sourcing; without local administration, the drug cannot be used and may not clear customs.
How do I avoid scams?
Use an operator that publishes its license number, accepts only bank wires, provides DSCSA paperwork, and routes the drug to a treating physician, not to your home address.
Related on Reserve Meds
- Drug catalog
- Conditions
- Access pathways
- Countries
- Access guides
- First shipment guide
- Counterfeit drug risk
Sources
- ASCO - Cancer.Net patient information
- FDA - Expanded Access (Compassionate Use)
- FDA - For Patients
- WHO - Access to medicines and health products
Start a request
Reviewed 2026-05-18 · Next review: 2026-11-18